Publicaciones en colaboración con investigadores/as de Universidade de Santiago de Compostela (10)

2022

  1. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

1990

  1. K-channel blocking drugs induce histamine release and <sup>45</sup>Ca uptake in isolated mast cells

    International Archives of Allergy and Immunology, Vol. 92, Núm. 2, pp. 162-167

1988

  1. Dual effect of dihydropyridines on 45Ca uptake induced by the K+ —channel blocker 4‐aminopyridin on mast cells

    Journal of Cellular Physiology, Vol. 137, Núm. 2, pp. 378-383

  2. Effect of colchicine on histamine secretion and calcium uptake in mast cells

    Revista española de fisiología, Vol. 44, Núm. 1, pp. 35-40

1987

  1. Adrenergic activity on rat pleural and peritoneal mast cells. Loss of β-receptors during the purification procedure

    General Pharmacology, Vol. 18, Núm. 2, pp. 141-148

  2. Hydralazine-relaxing effect on rat aorta is not mediated through changes in ATPase activity

    Archives Internationales de Pharmacodynamie et de Therapie, Vol. 285, Núm. 1, pp. 72-79

  3. Valinomycin, a degranulating agent in rat mast cells which inhibits calcium-uptake

    Agents and Actions, Vol. 22, Núm. 3-4, pp. 189-196

1986

  1. Effect of calcium on histamine release from pleural and peritoneal mast cells induced by catechol

    Revista Espanola de Fisiologia, Vol. 42, Núm. 4, pp. 455-458

  2. SECRECION DE HISTAMINA INDUCIDA POR EL COMPUESTO 48/80 EN MASTOCITOS: REQUERIMIENTOS METABOLICOS DURANTE LA EXOCITOSIS

    Anales de la Real Academia de Farmacia, Vol. 52, Núm. 2, pp. 349-354

1985

  1. Difference in, an influence of the purification medium on, sensitivity and maximum response of peritoneal and pleural mast cells stimulated by certain polyamines

    Agents and Actions, Vol. 16, Núm. 5, pp. 342-345